Economic impact of recombinant activated factor VII in the control of bleeds associated with abdominal prostatectomy

References

• Wilson K, Hebert PC. The challenge of increasingly expensive blood system. Canadian Medical Association Journal 2003; 168: 1149–1150.
   Google Scholar
• Varney SJ, Guest JF. The annual cost of blood transfusion in the UK. Transfusion Medicine 2003; 13: 205–218.
   PubMed Web of Science ®Google Scholar
• Chamberland ME. Emerging infectious agents: do they pose a risk to the safety of transfused blood and blood products. Clinical Infectious Diseases 2002; 34: 797–805.
   PubMed Web of Science ®Google Scholar
• Nash PA, Schrpferman RG, Rowland RG et al. The impact of pre-donated autologous blood and intra-operative isovolaemic haemodilution on the outcome of transfusion in patients undergoing radical retro-pubic prostatectomy. British Journal of Urology 1996; 77: 856–860.
   PubMedGoogle Scholar
• Dodd RV. The risk of transfusion- transmitted infection. New England Journal of Medicine 1992; 327: 419–420.
   PubMed Web of Science ®Google Scholar
• Gaylis FD, Friedel WE, Armas OA. Radical retro-pubic prostatectomy outcomes at a community hospital. Journal of Urology 1998; 159: 167–171.
   PubMedGoogle Scholar
• Andriole GI, Smith DS, Rao G et al. Early complications of retro-pubic prostatectomy. Journal of Urology 1994; 152: 1858–1860.
   PubMed Web of Science ®Google Scholar
• Ness PM, Bourke DL, Walsh PC. A randomized trial of perioperative hemodilution of preoperatively deposited autologous blood in elective surgery. Transfusion 1991; 31: 226–230.
   Google Scholar
• Goad JR, Eastham JA, Fitzgerald KB et al. Radical retropubic prostatectomy: limited benefit of autologous blood donation. Journal of Urology 1995; 154: 2103–2109.
   PubMedGoogle Scholar
• Villers A, Rebillard X. [Prostate cancer surgery]. La Revue du Praticien 2003; 53: 2246–2252.
   PubMedGoogle Scholar
• Melman A, Boczko J, Figueroa J et al. Critical surgical techniques for radical perineal prostatectomy. Journal of Urology 2004; 171: 786–790.
   PubMedGoogle Scholar
• Hu JC, Elkin EP, Pasta DJ et al. Predicting quality of life after radical prostatectomy: results from CaPSURE. Journal of Urology 2004; 171: 703–707; discussion 707–708.
   Google Scholar
• Cagiannos I, Karakiewicz P, Graefen M et al. Is year of radical prostatectomy a predictor of outcome in prostate cancer? Journal of Urology 2004; 171: 692–696.
   Google Scholar
• Oefelein MG, Colangelo LA, Rademaker AW et al. Intraoperative blood loss and prognosis in prostate cancer patients undergoing radical retropubic prostatectomy. Journal of Urology 1995; 154: 442–447.
   PubMed Web of Science ®Google Scholar
• Goh M, Kleer CG, Kelczewski P et al. Autologous blood donation prior to anatomical radical retropubic prostatectomy: is it necessary? italic>Urology 1997; 49: 569–574.
   Google Scholar
• Chun TY, Martin S, Herbert L. Preoperative recombinant human erythropoietin injection versus preoperative autologous blood donation in patients undergoing radical retropubic prostatectomy. Urology 1997; 50: 727–732.
   PubMed Web of Science ®Google Scholar
• Shapiro AD, Gilchrist GS, Hoots WK et al. Prospective, randomized trial of two doses of rFVIIa (NovoSeven) in haemophilia patients with inhibitors undergoing surgery. Thrombosis and Haemostasis 1998; 80: 773–778.
   PubMed Web of Science ®Google Scholar
• Roberts HR. Clinical experience with activated factor VII: focus on safety aspects. Blood Coagulation & Fibrinolysis 1998; 9 (Suppl 1): s115–s118.
   PubMedGoogle Scholar
• Odeyemi IAO, Guest JF. Modelling the economic impact of recombinant activated factor VII and activated prothrombin- complex concentrates in the treatment of a mild to moderate bleed in adults with inhibitors to clotting factors VIII and IX at a comprehensive centre in the UK. Journal of Medical Economics 2002; 5: 51–64.
   Google Scholar
• Odeyemi IAO, Guest JF. Modelling the economic impact of recombinant activated factor VII and activated prothrombin- complex concentrates in the home treatment of a mild to moderate bleed in adults with inhibitors to clotting factors VIII and IX in the UK. Journal of Medical Economics 2002; 5: 119–133.
   Google Scholar
• Friederich PW, Henny CP, Messelink EJ et al. Effect of recombinant activated factor VII on peri-operative blood loss in patients undergoing retro-pubic prostatectomy: a double-blind placebo-controlled randomized trial. Lancet 2003; 361: 201–205.
   PubMed Web of Science ®Google Scholar
• Z-index. Taxe, July 2003. Wet Tarieven Gezondheidszorg (WTG) – Geneesmiddelen. The Hague, The Netherlands.
   Google Scholar
• Tarieflijst + Bijlage bij Tarieflijst Instellingen, College Tarieven Gezondheidszorg (CTG). July 2003. Utrecht, The Netherlands. (www.ctg-zorg.nl).
   Google Scholar
• Tariefboek Medisch Specialisten. College Tarieven Gezondheidszorg. July 2003. Utrecht, The Netherlands.
   Google Scholar
• Cremieux PY, Barrett B, Anderson K et al. Cost of outpatient blood transfusion in cancer patients. Journal of Clinical Oncology 2000; 18: 2755–2761.
   PubMed Web of Science ®Google Scholar
• Etchason J, Lawrence P, Keeler E et al. The cost effectiveness of preoperative autologous blood donations. New England Journal of Medicine 1995; 332: 719–724.
   PubMed Web of Science ®Google Scholar
• Sonnenberg FA. A health economic analysis of autologous transfusion. Transfusion Medicine and Hemotherapy 2002; 29: 175–183.
   Google Scholar
• Goodnough LT, Bodner MS, Martin JW. Blood transfusion and blood conservation: cost and utilization issues. American Journal of Medical Quality 1994; 9: 172–183.
   PubMedGoogle Scholar
• Makhlouf AA, Boyd JC, Chapman TN et al. Perioperative costs and charges of prostate brachytherapy and prostatectomy. Urology 2002; 60: 656–660.
   PubMedGoogle Scholar
• Ramsden AR, Thurairaja R, Persad R et al. Current trends in the management of radical retropubic prostatectomy: is short-stay RRP feasible in the United Kingdom? Prostate Cancer and Prostatic Diseases 2004; 7: 50–53.
   PubMedGoogle Scholar
• Smith JA Jr, Koch MO. Radical prostatectomy: balancing cost and patient care. The Canadian Journal of Urology 1997; 4 (Suppl 1): 34–38.
   PubMedGoogle Scholar
• Klein EA, Kupelian PA. Localized prostate cancer: radiation or surgery? Urologic Clinics of North America 2003; 30: 315–330, ix.
   Google Scholar
• Turini M, Redaelli A, Gramegna P et al. Quality of life and economic considerations in the management of prostate cancer. Pharmacoeconomics 2003; 21: 527–541.
   PubMedGoogle Scholar
• Currie CJ, Patel, TC, McEwan P et al. Evaluation of the future supply and demand for blood products in the United Kingdom National Health Service. Transfusion Medicine 2004, 14: 19–24.
   Google Scholar
• Abshire T, Kenet G. Recombinant factor VIIa: review of efficacy, dosing regimens and safety in patients with congenital and acquired factor VII or IX inhibitors. Journal of Thrombosis and Haemostasis 2004, 2: 899–909.
   PubMed Web of Science ®Google Scholar